Drawing for VISICLEAR

USPTO serial 99625041

VISICLEAR

Reviewed by CopyMark Law Group

Status 681
Filing date
Status date
Registration date
—
Examiner
COHEN, ROBERT ANDREW
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with VISICLEAR?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Peixin Zhang

Peixin Zhang Law Offices of James Zhou17700 Castleton St #568City of Industry, CA 91748United States

Goods and services

ClassDescriptionStatusFirst use
005Antibiotics for human use; Amino acid preparations for medical purposes; Human growth hormone; Nutraceuticals for use as a dietary supplement; Vitamin supplement patches; Probiotic preparations for medical use; Dietetic foods adapted for medical purposes; Food for babies; Nutritional supplements; Enzyme dietary supplementsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 20, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 20, 2026RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Apr 22, 2026GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Apr 22, 2026GNSLLETTER OF SUSPENSION E-MAILED—
Apr 22, 2026CNSLSUSPENSION LETTER WRITTEN—
Apr 12, 2026DOCKASSIGNED TO EXAMINER—
Jan 30, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Jan 30, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 30, 2026NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance